Advancing gastrointestinal permeation enhancement formulations into the clinic: GIPET™

Modified-Release Drug Delivery Technology, Second Edition

Volumn 1, Issue , 2008, Pages 239-249

  Coughlan, David C ^a   O’Toole, Edel ^a   Leonard, Thomas W ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b Merrion Pharmaceuticals LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 71549120158     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (11)

1. Amidon G, Lennernas H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vitro bioavailability. Pharm Res 1995; 12(3): 413-20.
2. Sawada T, Ogawa T, Tomita M, et al. Role of paracellular pathway in nonelectrolyte permeation across rat colon epithelium enhanced by sodium caprate and sodium caprylate. Pharm Res 1991; 8(11): 1365-71.
3. Anderberg EK, Lindmark T, Artursson P. Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm Res 1993; 10(6): 857-64.
4. Braydon D, Creed E, O’Connell A, et al. Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers. Pharm Res 1997; 14(12): 1772-9.
5. Physicians’ Desk Reference. 59th ed. Montvale, NJ: Thompson PDR; 2005:2049-57.
6. Cramer JA, Amonkar MM, Mayur M, et al. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 2005; 21(9): 1453-60.
7. Gordon DH. Efficacy and safety of intravenous bisphosphonates for patients with breast cancer metastatic to bone: a review of randomized, double-blind, phase III trials. Clin Breast Cancer 2005; 6(2): 125-31.
8. Merli G. Anticoagulants in the treatment of deep vein thrombosis. Am J Med 2005; 118(Suppl. 8A): 13S-20S.
9. Hera, 2002. Hera Targeted Risk Assessment of Fatty Acid Salts. June 2002.
10. JECFA. 29th Report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series No. 733, 1986.
11. SCF. Extracts from First Report on Chemically Defined Flavoring Substances, 1995.